Revvity Inc (RVTY)
124.82
+3.78
(+3.12%)
USD |
NYSE |
Nov 04, 16:00
124.81
-0.01
(-0.01%)
Pre-Market: 07:46
Revvity Enterprise Value: 17.31B for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 17.31B |
| November 01, 2024 | 16.85B |
| October 31, 2024 | 16.55B |
| October 30, 2024 | 16.72B |
| October 29, 2024 | 16.44B |
| October 28, 2024 | 16.41B |
| October 25, 2024 | 16.27B |
| October 24, 2024 | 16.24B |
| October 23, 2024 | 16.54B |
| October 22, 2024 | 16.57B |
| October 21, 2024 | 16.63B |
| October 18, 2024 | 16.68B |
| October 17, 2024 | 16.60B |
| October 16, 2024 | 16.74B |
| October 15, 2024 | 17.26B |
| October 14, 2024 | 17.08B |
| October 11, 2024 | 16.91B |
| October 10, 2024 | 16.75B |
| October 09, 2024 | 16.91B |
| October 08, 2024 | 16.97B |
| October 07, 2024 | 17.03B |
| October 04, 2024 | 17.21B |
| October 03, 2024 | 17.23B |
| October 02, 2024 | 17.35B |
| October 01, 2024 | 17.27B |
| Date | Value |
|---|---|
| September 30, 2024 | 17.68B |
| September 27, 2024 | 17.47B |
| September 26, 2024 | 17.50B |
| September 25, 2024 | 16.98B |
| September 24, 2024 | 17.33B |
| September 23, 2024 | 16.98B |
| September 20, 2024 | 17.08B |
| September 19, 2024 | 17.52B |
| September 18, 2024 | 17.29B |
| September 17, 2024 | 17.05B |
| September 16, 2024 | 17.07B |
| September 13, 2024 | 16.97B |
| September 12, 2024 | 16.74B |
| September 11, 2024 | 16.84B |
| September 10, 2024 | 16.85B |
| September 09, 2024 | 16.57B |
| September 06, 2024 | 16.15B |
| September 05, 2024 | 16.37B |
| September 04, 2024 | 16.43B |
| September 03, 2024 | 16.69B |
| August 30, 2024 | 17.03B |
| August 29, 2024 | 16.99B |
| August 28, 2024 | 16.88B |
| August 27, 2024 | 17.02B |
| August 26, 2024 | 16.87B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
9.307B
Minimum
Mar 16 2020
29.80B
Maximum
Dec 30 2021
18.09B
Average
16.86B
Median
Aug 28 2023
Enterprise Value Benchmarks
| Bionano Genomics Inc | 24.70M |
| Avantor Inc | 19.98B |
| Bruker Corp | 11.01B |
| Azenta Inc | 1.602B |
| Harvard Bioscience Inc | 134.55M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 55.36M |
| Revenue (Quarterly) | 691.68M |
| Total Expenses (Quarterly) | 607.87M |
| EPS Diluted (Quarterly) | 0.45 |
| Gross Profit Margin (Quarterly) | 55.73% |
| Profit Margin (Quarterly) | 8.00% |
| Earnings Yield | 1.10% |
| Operating Earnings Yield | 1.79% |
| Normalized Earnings Yield | 1.455 |